Neuphoria Therapeutics Inc. Common Stock (NEUP) is a publicly traded Healthcare sector company. As of September 18, 2026, NEUP trades at $3.74 with a market cap of $20.08M and a P/E ratio of -16.37. NEUP moved +0.00% today. Year to date, NEUP is -3.14%; over the trailing twelve months it is -60.64%. Its 52-week range spans $3.19 to $21.40. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces NEUP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover NEUP: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $3.74 |
| Market Cap | $20.08M |
| P/E Ratio | -16.37 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.40 |
| 52-Week Low | $3.19 |
| Volume | 8.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.65M |
| Net Income | $-369.63K |
| Gross Margin | 0.00% |
1 analysts cover NEUP: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.